391 - 400 of 4301 Drugs
Amlobenz (amlodipine besylate and benazepril hydrochloride capsules)
Amlobenz (amlodipine besylate and benazepril hydrochloride capsules) is a combination of a dihydropyridine calcium channel blocker (DHP CCB) and an angiotensin converting enzyme (ACE) inhibitor indicated for the treatment of hypertension in patients not adequately controlled on monotherapy with either agent.
Consensi (amlodipine and celecoxib tablets)
Consensi (amlodipine and celecoxib) is a combination of a calcium channel blocker and a nonsteroidal anti-inflammatory drug (NSAID) indicated for patients for whom treatment with amlodipine for high blood pressure (hypertension) and celecoxib for osteoarthritis are appropriate. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular (CV) events, primarily strokes and heart attacks (myocardial infarctions).
Concensi (amlodipine and celecoxib tablet)
Consensi (amlodipine and celecoxib) is a combination of a calcium channel blocker and a nonsteroidal anti-inflammatory drug (NSAID) indicated for patients for whom treatment with amlodipine for high blood pressure (hypertension) and celecoxib for osteoarthritis are appropriate. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and heart attacks (myocardial infarctions).
Azor (amlodipine and olmesartan medoxomil tablets)
Azor (amlodipine and olmesartan medoxomil) is a combination of a calcium channel blocker and an angiotensin II receptor antagonist used to treat high blood pressure (hypertension).
Exforge (amlodipine and valsartan)
Exforge (amlodipine and valsartan) is a combination of a calcium channel blocker and an angiotensin II receptor antagonist used to treat high blood pressure (hypertension). Exforge is usually given after other drugs have been tried without successful treatment of hypertension.
Norvasc (amlodipine besylate)
Norvasc (amlodipine) is a calcium channel blocker (CCB) prescribed for the prevention and treatment of heart pain or chest pain from angina, and for the treatment of high blood pressure. Norvasc is available as a generic drug.
Lotrel (amlodipine besylate and benazepril hcl)
Lotrel (amlodipine besylate and benazepril hydrochloride) is a combination of an angiotensin-converting enzyme (ACE) inhibitor and a calcium channel blocker used for treatment of high blood pressure (hypertension) that is resistant to treatment by either amilodipine or benzapril alone. Lotrel is used usually after one of the other drugs has failed to control the patient's hypertension. Lotrel is available in generic form.
Caduet (amlodipine besylate, atorvastatin calcium)
Caduet (amlodipine besylate and atorvastatin calcium) is a combination of a calcium channel blocker and a statin drug used to treat high blood pressure (hypertension) or chest pain (angina) that occurs with high cholesterol or triglyceride levels. Common side effects of Caduet include dizziness or lightheadedness as your body adjusts to the medication.
Norliqva (amlodipine oral solution)
Norliqva (amlodipine) is a calcium channel blocker used for the treatment of high blood pressure (hypertension) in adults and children 6 years of age and older, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Norliqva is also used for the treatment of coronary artery disease, including chronic stable angina, vasospastic angina (Prinzmetal's or variant angina), and angiographically documented coronary artery disease in patients without heart failure or an ejection fraction less than 40%.
Katerzia (amlodipine oral suspension)
Katerzia (amlodipine) is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of hypertension in adults and children 6 years and older, to lower blood pressure and coronary artery disease, including chronic stable angina, vasospastic angina (Prinzmetal's or variant angina), and angiographically documented coronary artery disease in patients without heart failure or an ejection fraction less than 40%.